First Responders With More Debris Exposure Have Higher Risk of Early Dementia
By Lori Solomon HealthDay Reporter
FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65 years, according to a study published online June 12 in JAMA Network Open.
Sean A.P. Clouston, Ph.D., from Stony Brook University in New York, and colleagues assessed the incidence of dementia at <65 years in a prospective study (2014 through 2022) of WTC responders. Analysis included data from 5,010 responders with exposure severity data.
The researchers found that increasing WTC exposure severity was associated with incremental increases in the incidence rate of dementia (low exposure: 2.95 per 1,000 person-years; mild: 12.16; moderate: 16.53; high: 30.09; and severe: 42.37). Each unit increase in exposure severity was associated with increased incidence of dementia when adjusting for social, demographic, and relevant medical factors (adjusted hazard ratio, 1.42; mean risk difference, 9.74 per 1,000 person-years).
"Disasters often require an emergent response in dangerous conditions, but reliable use of personalized protective equipment might help prevent the onset of dementia before age 65 years among individuals exposed to an uncontrolled building collapse," the authors write. "Future research is warranted to determine cerebral biomarkers for individuals with exposure-associated dementia."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-15 03:15
Read more
- Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression
- Grandparents & Grandkids: Poll Shows Them Helping Each Other
- Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
- Colonoscopy Still Beats New Blood Tests at Spotting Colon Cancer
- Fish Oil Supplements Might Help Prevent Cancer
- Obesity Could Cause 40% of Hormone-Positive Breast Cancers in Older Women
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions